Upcoming Issue Highlights
Home Subscribe Advertise Sourcebook Free Product Info Home

Lipogen Builds Phospholipids R&D Center


Lipogen Builds Phospholipids R&D center (2)

Non-GMO Project

Lipogen Ltd. (Haifa, Israel) is expanding its production facilities and building a new phospholipids research and development center in response to a rapid  jump in sales of brain and stress health solutions in Q1-Q3 2015.

Lipogen invested $2.6 million (U.S.) in building two additional production lines for PhosphatidylSerine (PS) and Phosphatidic Acid (PA). The company also added 10,000 square feet to its facilities to double production capabilities for PS and PA. Upgrades include automated controlled processing to reduce production costs through improved production traceability, and implementing new safety methods, allowing Lipogen to produce its all-natural, non-GMO (genetically modified organism), solvent-free ingredients in accordance with the highest industry standards.

Lipogen drive innovation strategy of new phospholipid solutions

“Increasing demand for our brain health and stress management ingredients pushed us to establish a new growth strategy for our PS and PA product line,” said David Rutenberg, CEO of Lipogen. “The phospholipids market is expanding from traditional brain function support to new brain health concepts, including: stress management, cortisol control, ADHD mitigation, sports nutrition and more.”

Lipogen continues to research and develop new cognitive and stress management solutions based on proprietary technology and enzymatic process. The advanced, well-equipped phospholipids R&D center was designed to support product development and product research at Lipogen facilities. The company has appointed Abraham Rutenberg as vice president and R&D manager. In addition, Lipogen expanded its headquarters, appointing Ariel Gordon as vice president business development manager to develop new segments and markets for Lipogen’s leading brands.

“I’m excited to welcome Abraham Rutenberg and Ariel Gordon to our team,” said Rutenberg. “They will lead Lipogen to the next level via high-impact growth—not only in the dietary supplements industry, but also in the food, beverage and pharmaceuticals industries. Lipogen is committed to producing pure, high-quality products with minimal damage to the environment. We’ve initiated a long-term sustainability strategy for our complete product line.”

For more information, visit www.lipogenbio.com.